A Study to Examine the Safety, Tolerability and Biological Effects of Single Doses of Subcutaneously and Intravenously Administered Pozelimab as Monotherapy and in Combination With Single Doses of Subcutaneously Administered Cemdisiran in Adult Japanese Healthy Volunteers
Clinical trial NCT04940364 · COMPLETED
Trial details
- NCT number
- NCT04940364
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-04
- Primary completion
- 2022-06-22
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.